Annovis Bio, Inc. Share Price
ANVS$0.00
+0.00 (0.00%) Annovis Bio, Inc. Stock Performance
Open N/A | Prev. Close N/A | Circuit Range N/A |
Day Range N/A | Year Range N/A | Volume N/A |
Average Traded N/A |
Annovis Bio, Inc. Share Price Chart
$0.00
Please wait...
About Annovis Bio, Inc.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's lead product candidate is Buntanetap, which is in phase 2/3 to treat alzheimer's disease, as well as in phase 3 to treat parkinson's disease; and is in phase 2 clinical trial to treat lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial to treat later stages of alzheimer's disease and dementia. The company was incorporated in 2008 and is headquartered in Malvern, Pennsylvania.
Annovis Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|
FAQs on Annovis Bio, Inc. Share Price
Can I buy Annovis Bio, Inc. shares in India?
Yes. You can buy Annovis Bio, Inc. in India by opening an international trading account.
What is the share price of Annovis Bio, Inc.?
As on 01 Mar '26, the share price of Annovis Bio, Inc. ANVS is $0.00. If you are investing from India, it is a good idea to check the current exchange rate and calculate the value in rupees before making your investment.
What is the 5 year returns of Annovis Bio, Inc.?
The 5 year returns of Annovis Bio, Inc. is as on 01 Mar '26.
What are the high & low stock price of Annovis Bio, Inc. today?
Annovis Bio, Inc. stock price hit a high of $0.00 and low of $0.00 as on 01 Mar '26.
What is the 52-week high and low of Annovis Bio, Inc. stock?
The 52-week high of Annovis Bio, Inc. stock is $0.00, while the 52-week low is $0.00 as on 01 Mar '26.